Shi-Nan Wu

xia men university

H指数:15

被引数:891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A ROS-Responsive and Mucoadhesive Thermosensitive Hydrogel Encapsulated with Mizoribine for Synergistic Dry Eye Therapy

一种含霉酚酸包封的ROS响应性和粘附性温敏水凝胶，用于协同干眼症治疗

Advanced Science

IF14.1

2026-10-070

OAAI

Burden of cataract in the Western Pacific Region from 1990 to 2023: an analysis based on the Global Burden of Disease study

1990年至2023年西太平洋地区白内障负担：基于全球疾病负担研究的分析

npj Aging

IF6

2026-09-160

Global burden of early-onset mental disorders in adolescents and young adults: a systematic analysis based on the Global Burden of Disease study 2021

青少年和年轻成年人早期发病精神障碍的全球负担：一项基于2021年全球疾病负担研究的系统分析

BMC Psychiatry

IF3.6

2026-04-040

OAAI

Editorial: Frontier research on artificial intelligence and radiomics in neurodegenerative diseases

编辑ials：人工智能和放射组学在神经退行性疾病中的前沿研究

Frontiers in Neurology

IF2.8

2025-10-140

OAAI

药物相关性视网膜脱离的药物警戒信号在真实世界中的证据：来自FDA不良事件报告系统

Eye

IF3.2

2025-10-100

PRE

Real-world large sample evaluation of drug-related blepharoptosis: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database

真实世界大样本药物相关性上睑下垂评估：基于FDA不良事件报告系统数据库的药物警戒分析

Therapeutic Advances in Drug Safety

IF3.4

2025-09-220

药物相关视觉模糊：美国食品药品监督管理局不良事件报告系统数据库的研究发现

European Journal of Pharmacology

IF4.7

2025-06-070

PRE

Development of machine learning model for predicting prolonged operation time in lumbar stenosis undergoing posterior lumbar interbody fusion: a multicenter study

预测腰椎管狭窄症后路椎间融合术后延长手术时间的机器学习模型的建立: 一项多中心研究

SPINE JOURNAL

IF4.7

2025-03-010

PRE

Real world pharmacovigilance assessment of drug related macular degeneration risks

SCIENTIFIC REPORTS

IF3.9

2025-01-070

OAAI

Real-world analysis of medications inducing meibomian gland dysfunction: based on the FDA adverse event reporting system database

EXPERT OPINION ON DRUG SAFETY

IF3.1

2025-01-050

Association between systemic immune inflammation index and cataract incidence from 2005 to 2008

全身免疫炎症指数与2008年白内障发病2005年

SCIENTIFIC REPORTS

IF3.9

2025-01-022

OAAI

Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2024-12-191

OAAI

Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study

乳腺癌眼转移预测模型: 机器学习模型开发与解释研究

BMC CANCER

IF3.4

2024-11-290

OAAI

Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database

药物相关性青光眼: 基于食品和药物管理局不良事件报告系统数据库的真实世界研究

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

IF5.6

2024-10-251

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2024-10-160

OAAI

Real-World Large Sample Assessment of Drug-related Dry Eye Risk: Based on the FDA Adverse Event Reporting System Database

ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY

IF4.5

2024-09-012

OAAI

The impact of vitamin E, vitamin B6, and niacin intake on cataract incidence based on NHANES 2005-2008 data

FRONTIERS IN NUTRITION

IF5.1

2024-08-090

OAAI

Machine learning predictors of risk of death within 7 days in patients with non-traumatic subarachnoid hemorrhage in the intensive care unit: A multicenter retrospective study

HELIYON

IF3.6

2024-01-012

OAAI

Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study

HELIYON

IF3.6

2023-11-012

OAAI

Application and interpretation of machine learning models in predicting the risk of severe obstructive sleep apnea in adults

机器学习模型在成人重度阻塞性睡眠呼吸暂停风险预测中的应用与解读

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2023-10-199

OAAI

Shi-Nan Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向